BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30954024)

  • 21. Effects of Trace Amine-associated Receptor 1 Agonists on the Expression, Reconsolidation, and Extinction of Cocaine Reward Memory.
    Liu JF; Thorn DA; Zhang Y; Li JX
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26822713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat.
    Edgar DM; Seidel WF
    J Pharmacol Exp Ther; 1997 Nov; 283(2):757-69. PubMed ID: 9353396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TAAR1-dependent effects of apomorphine in mice.
    Sukhanov I; Espinoza S; Yakovlev DS; Hoener MC; Sotnikova TD; Gainetdinov RR
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1683-93. PubMed ID: 24925023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related behavioral indices of methamphetamine in rats.
    Jing L; Zhang Y; Li JX
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
    Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep electroencephalographic characteristics of the Cynomolgus monkey measured by telemetry.
    Rachalski A; Authier S; Bassett L; Pouliot M; Tremblay G; Mongrain V
    J Sleep Res; 2014 Dec; 23(6):619-627. PubMed ID: 25109588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice.
    Aleksandrov AA; Knyazeva VM; Volnova AB; Dmitrieva ES; Polyakova NV; Gainetdinov RR
    Front Pharmacol; 2019; 10():470. PubMed ID: 31130864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding.
    Dedic N; Wang L; Hajos-Korcsok E; Hecksher-Sørensen J; Roostalu U; Vickers SP; Wu S; Anacker C; Synan C; Jones PG; Milanovic S; Hopkins SC; Bristow LJ; Koblan KS
    Mol Metab; 2024 Feb; 80():101883. PubMed ID: 38237896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methamphetamine-induced impulsivity during chronic methamphetamine treatment in rats: Effects of the TAAR 1 agonist RO5263397.
    Xue Z; Siemian JN; Johnson BN; Zhang Y; Li JX
    Neuropharmacology; 2018 Feb; 129():36-46. PubMed ID: 29128305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The EEG effects of THIP (Gaboxadol) on sleep and waking are mediated by the GABA(A)delta-subunit-containing receptors.
    Winsky-Sommerer R; Vyazovskiy VV; Homanics GE; Tobler I
    Eur J Neurosci; 2007 Mar; 25(6):1893-9. PubMed ID: 17408425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
    Leo D; Targa G; Espinoza S; Villers A; Gainetdinov RR; Ris L
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects.
    Wu R; Liu J; Johnson B; Huang Y; Zhang Y; Li JX
    Addict Biol; 2022 Jan; 27(1):e13075. PubMed ID: 34170054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAAR1 Modulates Cortical Glutamate NMDA Receptor Function.
    Espinoza S; Lignani G; Caffino L; Maggi S; Sukhanov I; Leo D; Mus L; Emanuele M; Ronzitti G; Harmeier A; Medrihan L; Sotnikova TD; Chieregatti E; Hoener MC; Benfenati F; Tucci V; Fumagalli F; Gainetdinov RR
    Neuropsychopharmacology; 2015 Aug; 40(9):2217-27. PubMed ID: 25749299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats.
    Thorn DA; Zhang C; Zhang Y; Li JX
    Neurosci Lett; 2014 Apr; 566():67-71. PubMed ID: 24561093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers.
    James LM; Iannone R; Palcza J; Renger JJ; Calder N; Cerchio K; Gottesdiener K; Hargreaves R; Murphy MG; Boyle J; Dijk DJ
    Psychopharmacology (Berl); 2011 Jun; 215(4):643-53. PubMed ID: 21301819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking.
    Liu J; Johnson B; Wu R; Seaman R; Vu J; Zhu Q; Zhang Y; Li JX
    Br J Pharmacol; 2020 Aug; 177(15):3403-3414. PubMed ID: 32246467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous melatonin is not obligatory for the regulation of the rat sleep-wake cycle.
    Fisher SP; Sugden D
    Sleep; 2010 Jun; 33(6):833-40. PubMed ID: 20550025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine.
    Sukhanov I; Dorofeikova M; Dolgorukova A; Dorotenko A; Gainetdinov RR
    Front Pharmacol; 2018; 9():329. PubMed ID: 29681856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.